XERIS BIOPHARMA HOLDINGS, INC. (XERS) Operating cash flow 2020–2025
XERIS BIOPHARMA HOLDINGS, INC. (XERS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$28.6MFY2025 · since FY2020: -$80.6M → $28.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $28.6M | +177.4% |
| FY2024 | -$37.0M | +21.4% |
| FY2023 | -$47.0M | +54.3% |
| FY2022 | -$102.9M | -7.7% |
| FY2021 | -$95.5M | -18.6% |
| FY2020 | -$80.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice